- Home
- SNBR vs INAB Comparison
SNBR vs INAB Comparison
Compare SNBR & INAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNBR
- INAB
- Stock Information
- Founded
- SNBR 1987
- INAB 2016
- Country
- SNBR United States
- INAB United States
- Employees
- SNBR N/A
- INAB N/A
- Industry
- SNBR Home Furnishings
- INAB Biotechnology: Pharmaceutical Preparations
- Sector
- SNBR Consumer Discretionary
- INAB Health Care
- Exchange
- SNBR Nasdaq
- INAB Nasdaq
- Market Cap
- SNBR 261.1M
- INAB 24.0M
- IPO Year
- SNBR 1998
- INAB 2021
- Fundamental
- Price
- SNBR $16.74
- INAB $0.25
- Analyst Decision
- SNBR Hold
- INAB Strong Buy
- Analyst Count
- SNBR 3
- INAB 3
- Target Price
- SNBR $12.83
- INAB $7.75
- AVG Volume (30 Days)
- SNBR 368.6K
- INAB 727.4K
- Earning Date
- SNBR 10-30-2024
- INAB 11-12-2024
- Dividend Yield
- SNBR N/A
- INAB N/A
- EPS Growth
- SNBR N/A
- INAB N/A
- EPS
- SNBR N/A
- INAB N/A
- Revenue
- SNBR $1,734,997,000.00
- INAB N/A
- Revenue This Year
- SNBR N/A
- INAB N/A
- Revenue Next Year
- SNBR $1.68
- INAB N/A
- P/E Ratio
- SNBR N/A
- INAB N/A
- Revenue Growth
- SNBR N/A
- INAB N/A
- 52 Week Low
- SNBR $8.13
- INAB $0.22
- 52 Week High
- SNBR $20.75
- INAB $1.93
- Technical
- Relative Strength Index (RSI)
- SNBR 47.89
- INAB 39.26
- Support Level
- SNBR $18.36
- INAB $0.28
- Resistance Level
- SNBR $20.00
- INAB $0.32
- Average True Range (ATR)
- SNBR 1.35
- INAB 0.03
- MACD
- SNBR -0.26
- INAB -0.01
- Stochastic Oscillator
- SNBR 26.86
- INAB 13.73
About SNBR Sleep Number Corporation
Sleep Number Corp. is a wellness technology company engaged in the design, manufacturing, marketing and distribution of sleep solutions. The Company generates revenue by marketing and selling its smart beds directly to new and existing customers through its vertically integrated, exclusive, direct-to-consumer retail touch points including Stores, Online, Phone, and Chat (Total Retail). The products offered by the company are Mattresses, Bedding, Pillows and Furniture.
About INAB IN8bio Inc.
IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.